High-grade salivary-gland involvement, assessed by histology or ultrasonography, is associated with a poor response to a single rituximab course in primary Sjögren's syndrome: Data from the TEARS randomized trial

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Cornec, Divi ^a,b   Jousse Joulin, Sandrine ^a,b   Costa, Sebastian ^c   Marhadour, Thierry ^a   Marcorelles, Pascale ^c   Berthelot, Jean Marie ^d   Hachulla, Eric ^e   Hatron, Pierre Yves ^e   Goeb, Vincent ^f   Vittecoq, Olivier ^f   Nowak, Emmanuel ^g   Pers, Jacques Olivier ^b   Devauchelle Pensec, Valérie ^a,b   Saraux, Alain ^a,b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b Universite de Brest   (France)

^c CHU MORVAN   (France)

^d HÔTEL DIEU   (France)

^e UNIV LILLE   (France)

^f Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^g BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RITUXIMAB;

ADULT; ARTICLE; DISEASE SEVERITY; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALIVA ANALYSIS; SALIVARY GLAND; SALIVARY GLAND BIOPSY; SALIVATION; SINGLE DRUG DOSE; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND; TREATMENT RESPONSE; XEROPHTHALMIA; XEROSTOMIA;

EID: 84992089849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162787     Document Type: Article

References (38)

1. Cornec D, Chiche L. Is primary Sjögren's syndrome an orphan disease? A critical appraisal of prevalence studies in Europe. Ann Rheum Dis. 2014; annrheumdis-2014-206860. doi: 10.1136/annrheumdis-2014-206860
2. Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, et al. Etanercept in Sjögren's syndrome: A twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum. 2004;50:2240-2245. doi: 10.1002/art.20299 PMID: 15248223
3. Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, et al. Inefficacy of infliximab in primary Sjögren's syndrome: Results of the randomized, controlled trial of remicade in primary Sjögren's syndrome (TRIPSS). Arthritis Rheum. 2004;50:1270-1276. doi: 10.1002/art.20146 PMID: 15077311
4. Gottenberg J-E, Ravaud P, Puéchal X, Le Guern V, Sibilia J, Goeb V, et al. Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial. JAMA. 2014;312:249-258. doi: 10.1001/jama.2014.7682 PMID: 25027140
5. Cornec D, Devauchelle-Pensec V, Tobón GJ, Pers J-O, Jousse-Joulin S, Saraux A. B cells in Sjögren's syndrome: From pathophysiology to diagnosis and treatment. J Autoimmun. 2012;39:161-167. doi: 10.1016/j.jaut.2012.05.014 PMID: 22749831
6. Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot J-M, Perdriger A, Puéchal X, et al. Treatment of Primary Sjögren Syndröme With RituximabA Randomized Trial. Ann Intern Med. 2014;160:233-242. doi: 10.7326/M13-1085 PMID: 24727841
7. Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot J-M, Perdriger A, et al. Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy. Rheumatology. 2015; kev114. doi: 10.1093/rheumatology/kev114
8. Pijpe J, Van Imhoff GW, Spijkervet FKL, Roodenburg JLN, Wolbink GJ, Mansour K, et al. Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study. Arthritis Rheum. 2005;52:2740-2750. doi: 10.1002/art.21260 PMID: 16142737
9. Cornec D, Jousse-Joulin S, Pers J-O, Marhadour T, Cochener B, Boisramé-Gastrin S, et al. Contribution of salivary gland ultrasonography to the diagnosis of Sjögren's syndrome: Toward new diagnostic criteria? Arthritis Rheum. 2013;65:216-225. doi: 10.1002/art.37698 PMID: 23108632
10. Cornec D, Jousse-Joulin S, Marhadour T, Pers J-O, Boisramé-Gastrin S, Renaudineau Y, et al. Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjögren's syndrome. Rheumatology. 2014; keu037. doi: 10. 1093/rheumatology/keu037
11. Hammenfors DS, Brun JG, Jonsson R, Jonsson MV. Diagnostic utility of major salivary gland ultrasonography in primary Sjögren's syndrome. Clin Exp Rheumatol. 2015;33:56-62. PMID: 25535773
12. Theander E, Mandl T. Primary Sjögren's syndrome: diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system. Arthritis Care Res. 2014;66:1102-1107. doi: 10. 1002/acr.22264
13. Takagi Y, Sumi M, Nakamura H, Iwamoto N, Horai Y, Kawakami A, et al. Ultrasonography as an additional item in the American College of Rheumatology classification of Sjögren's syndrome. Rheumatol Oxf Engl. 2014;53:1977-1983. doi: 10.1093/rheumatology/keu238
14. Baldini C, Luciano N, Tarantini G, Pascale R, Sernissi F, Mosca M, et al. Salivary gland ultrasonography: a highly specific tool for the early diagnosis of primary Sjögren's syndrome. Arthritis Res Ther. 2015;17:146. doi: 10.1186/s13075-015-0657-7 PMID: 26022533
15. Delli K, Dijkstra PU, Stel AJ, Bootsma H, Vissink A, Spijkervet FKL. Diagnostic properties of ultrasound of major salivary glands in Sjögren's syndrome: a meta-analysis. Oral Dis. 2015;21:792-800. doi: 10. 1111/odi.12349 PMID: 25988616
16. Cornec D, Devauchelle-Pensec V, Saraux A, Jousse-Joulin S. [Clinical usefulness of salivary gland ultrasonography in Sjögren's syndrome: Where are we now?]. Rev Medecine Interne Fondee Par Societe Natl Francaise Medecine Interne. 2016;37:186-194. doi: 10.1016/j.revmed.2015.10.341
17. Jousse-Joulin S, Milic V, Jonsson MV, Plagou A, Theander E, Luciano N, et al. Is salivary gland ultrasonography a useful tool in Sjögren's syndrome? A systematic review. Rheumatol Oxf Engl. 2015; doi: 10.1093/rheumatology/kev385
18. Cornec D, Jousse-Joulin S, Saraux A, Devauchelle-Pensec V. Salivary gland ultrasound to diagnose Sjögren's syndrome: a claim to standardize the procedure. Rheumatol Oxf Engl. 2015;54:199-200. doi: 10.1093/rheumatology/keu397
19. Jousse-Joulin S, Devauchelle-Pensec V, Cornec D, Marhadour T, Bressollette L, Gestin S, et al. Ultrasonographic salivary gland response to rituximab in primary Sjögren's syndrome. Arthritis Rheumatol Hoboken NJ. 2015; doi: 10.1002/art.39088
20. Risselada AP, Kruize AA, Goldschmeding R, Lafeber FPJG, Bijlsma JWJ, Van Roon JAG. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome. Ann Rheum Dis. 2014;73:1537-1540. doi: 10.1136/annrheumdis-2013-204634 PMID: 24525912
21. Carubbi F, Alunno A, Cipriani P, Di Benedetto P, Ruscitti P, Berardicurti O, et al. Is minor salivary gland biopsy more than a diagnostic tool in primary Sjögren's syndrome? Association between clinical, histopathological, and molecular features: a retrospective study. Semin Arthritis Rheum. 2014;44:314-324. doi: 10.1016/j.semarthrit.2014.05.015 PMID: 24935529
22. Fisher BA, Brown RM, Bowman SJ, Barone F. A review of salivary gland histopathology in primary Sjögren's syndrome with a focus on its potential as a clinical trials biomarker. Ann Rheum Dis. 2015; annrheumdis-2015-207499. doi: 10.1136/annrheumdis-2015-207499
23. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-558. PMID: 12006334
24. Costa S, Quintin-Roué I, Lesourd A, Jousse-Joulin S, Berthelot J-M, Hachulla E, et al. Reliability of histopathological salivary gland biopsy assessment in Sjögren's syndrome: a multicentre cohort study. Rheumatol Oxf Engl. 2014; doi: 10.1093/rheumatology/keu453
25. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome. Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum. 1984;27:147-156. PMID: 6696772
26. Jorkjend L, Johansson A, Johansson A-K, Bergenholtz A. Resting and stimulated whole salivary flow rates in Sjögren's syndrome patients over time: a diagnostic aid for subsidized dental care? Acta Odontol Scand. 2004;62:264-268. PMID: 15841813
27. Pijpe J, Kalk WWI, Bootsma H, Spijkervet FKL, Kallenberg CGM, Vissink A. Progression of salivary gland dysfunction in patients with Sjögren's syndrome. Ann Rheum Dis. 2007;66:107-112. doi: 10. 1136/ard.2006.052647 PMID: 16728458
28. Samier-Guérin A, Saraux A, Gestin S, Cornec D, Marhadour T, Devauchelle-Pensec V, et al. Can ARFI elastometry of the salivary glands contribute to the diagnosis of Sjögren's syndrome? Jt Bone Spine Rev Rhum. 2015; doi: 10.1016/j.jbspin. 2015.11.002
29. Knopf A, Hofauer B, Thürmel K, Meier R, Stock K, Bas M, et al. Diagnostic utility of Acoustic Radiation Force Impulse (ARFI) imaging in primary Sjoegren's syndrome. Eur Radiol. 2015;25:3027-3034. doi: 10.1007/s00330-015-3705-4 PMID: 25861884
30. Zhang S, Zhu J, Zhang X, He J, Li J. Assessment of the Stiffness of Major Salivary Glands in Primary Sjögren's Syndrome through Quantitative Acoustic Radiation Force Impulse Imaging. Ultrasound Med Biol. 2016;42:645-653. doi: 10.1016/j.ultrasmedbio.2015.11.009 PMID: 26715188
31. Pijpe J, Kalk WWI, Wal Van Der JE, Vissink A, Kluin PM, Roodenburg JLN, et al. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjögren's syndrome. Rheumatology. 2007;46:335-341. doi: 10.1093/rheumatology/kel266 PMID: 16891656
32. Devauchelle-Pensec V, Pennec Y, Morvan J, Pers J-O, Daridon C, Jousse-Joulin S, et al. Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Care Res. 2007;57:310-317. doi: 10.1002/art.22536
33. Costa S, Schutz S, Cornec D, Uguen A, Quintin-Roue I, Lesourd A, et al. B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixelbased digital procedure. Arthritis Res Ther. 2016;18:21. doi: 10.1186/s13075-016-0924-2 PMID: 26785742
34. Cornec D, Costa S, Devauchelle-Pensec V, Jousse-Joulin S, Marcorelles P, Berthelot J-M, et al. Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome. J Autoimmun. 2016;67:102-110. doi: 10.1016/j.jaut.2015.11.002 PMID: 26688003
35. Delli K, Haacke EA, Kroese FGM, Pollard RP, Ihrler S, Vegt Van Der B, et al. Towards personalised treatment in primary Sjögren's syndrome: baseline parotid histopathology predicts responsiveness to rituximab treatment. Ann Rheum Dis. 2016; annrheumdis-2015-208304. doi: 10.1136/annrheumdis-2015-208304
36. Cornec D, Costa S, Devauchelle-Pensec V, Chiche L, Saraux A, Pers J-O. Do high numbers of salivary gland-infiltrating B cells predict better or worse outcomes after rituximab in patients with primary Sjögren's syndrome? Ann Rheum Dis. 2016; doi: 10.1136/annrheumdis-2016-209300
37. Delli K, Haacke EA, Kroese FG, Pollard RP, Ihrler S, Van Der Vegt B, et al. In primary Sjögren's syndrome high absolute numbers and proportions of B cells in parotid glands predict responsiveness to rituximab as defined by ESSDAI, but not by SSRI. Ann Rheum Dis. 2016; doi: 10.1136/annrheumdis-2016-209317
38. Brown S, Coy NN, Pitzalis C, Emery P, Pavitt S, Gray J, et al. The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren's Syndrome. BMC Musculoskelet Disord. 2014;15:21. doi: 10.1186/1471-2474-15-21 PMID: 24438039